Nouvelles de la Bourse
Dernières actualités financières · Mis à jour Mai 23, 2026
Pourquoi l'action Palo Alto Networks a chuté aujourd'hui
Why Palo Alto Networks Stock Dropped Today
The panel generally agreed that the 7% drop in PANW was due to overvaluation and unfounded rumors about Anthropic's Claude …
Eli Lilly contre Novo Nordisk : Quelle action de médicament contre l'obésité est le meilleur achat ?
Eli Lilly vs Novo Nordisk: Which Obesity Drug Stock Is the Better Buy?
The discussion panel is divided on the valuation of Eli Lilly (LLY) and Novo Nordisk (NVO). While some argue LLY's …
Prédiction : Ethereum surpassera Bitcoin au cours des 3 prochaines années
Prediction: Ethereum Will Outperform Bitcoin Over the Next 3 Years
The panel's net takeaway is that Ethereum's (ETH) potential to outperform Bitcoin (BTC) over the next three years is uncertain …
L'action de Zenas BioPharma chute de 20 % après la fixation du prix d'une offre de 300 millions de dollars
Zenas BioPharma Stock Falls 20% After Pricing $300 Mln Offerings
The panel is divided on ZBIO's recent capital raise. While some see it as funding runway to key catalysts and …
EEM, UST : Sorties massives d'ETF
EEM, UST: Big ETF Outflows
The panel agrees that the 35.9% outflow from UST signals a significant de-risking from long-duration bets, likely driven by rising …
1 ETF à faible coût qui pourrait surperformer les fonds gérés activement cette année
1 Low-Cost ETF That Could Outperform Actively Managed Funds This Year
The panel agreed that VOO's heavy concentration in the 'Magnificent Seven' (33% weight) exposes it to tech/AI bubble risks, particularly …
CORO, EWJ, EWC, EWU : Alerte d'afflux d'ETF
CORO, EWJ, EWC, EWU: ETF Inflow Alert
The panelists agree that the article's analysis of CORO's inflows is flawed due to missing data and potential ticker confusion. …
AtaiBeckley obtient la note « Buy » dans la couverture initiale des analystes de Deutsche Bank
AtaiBeckley awarded ‘Buy’ rating in initial coverage from Deutsche Bank analysts
The panelists generally agreed that Deutsche Bank's $12 price target for ATAI Life Sciences, implying 320% upside, is overly optimistic …
Les médicaments à faible risque de Protagonist Therapeutics (PTGX) ont-ils un potentiel blockbuster ?
Do Protagonist Therapeutics’ (PTGX) Derisked Drugs Have Blockbuster Potential?
The panel is neutral on Protagonist Therapeutics (PTGX) at a $6.3B market cap, with concerns about competition in the IBD …
La CMA britannique enquête sur Just Eat pour de fausses notes en ligne
UK’s CMA probes Just Eat over misleading online ratings
The consensus among the panel is that the CMA's fact-finding probe into Just Eat's ratings system poses significant risks, primarily …
Une cour d'appel américaine annule un jugement de 16,1 milliards de dollars contre l'Argentine pour la saisie de YPF
US appeals court voids $16.1 billion judgment against Argentina over YPF seizure
The 2nd Circuit's ruling voids a major US-law legal overhang, providing immediate fiscal relief to Argentina and improving Milei's negotiating …
Logique, Logistique, Et Au Moins 10 Jours De Plus...
Logic, Logistics, And At Least Another 10 Days...
The panel agrees that the extension to April 6 increases geopolitical risks, with potential impacts on oil prices, insurance costs, …